Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 58 | 59 | +1 |
| Shares | 5.76M | 5.76M | −4.48K (−0.1%) |
| Value | $34.1M | $29.3M | −$4.86M (−14.3%) |
New holders (7)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 29,722 | $151.0K | 0.00% |
| BIT Capital GmbH | 19,776 | $100.5K | 0.01% |
| Virtu Financial LLC | 19,570 | $99.0K | 0.01% |
| Group One Trading, L.P. | 5,040 | $25.6K | 0.00% |
| Advisory Services Network, LLC | 2,120 | $10.8K | 0.00% |
| BFSG, LLC | 500 | $2.54K | 0.00% |
| Coppell Advisory Solutions LLC | 7 | $36 | 0.00% |
Sold out (6)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 18,002 | $106.6K |
| J. Goldman & Co LP | 13,500 | $79.9K |
| Manufacturers Life Insurance Company, The | 11,177 | $66.2K |
| Russell Investments Group, Ltd. | 39 | $231 |
| Nisa Investment Advisors, LLC | 32 | $189 |
| Signaturefd, LLC | 8 | $47 |